Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre, Non-interventional Retrospective Study of Treatment Outcomes From Treatment With Dysport ® (Clostridium Botulinum Type A Toxin-haemagglutinin Complex, Abobotulinumtoxin-A) Injections in Adults for Upper and/or Lower Limb Focal Spasticity in Real-world Clinical Practice in the United Kingdom

NCT04604379 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.

NCT NCT04604379
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04604379 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre, Non-interventional Retrospective Study of Treatment Outcomes From Treatment With Dysport ® (Clostridium Botulinum Type A Toxin-haemagglutinin Complex, Abobotulinumtoxin-A) Injections in Adults for Upper and/or Lower Limb Focal Spasticity in Real-world Clinical Practice in the United Kingdom
Lead sponsor
Ipsen
Phase
Observational
Overall status
Completed
Start date
February 4, 2021
Completion date
May 28, 2021
Enrollment
123 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

upper and/or lower limb focal spasticity